Antibodies‐to‐infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn’s disease

Corresponding Author

Phillip Minar

Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

University of Cincinnati College of Medicine, Cincinnati, OH, USA

Correspondence

Phillip Minar, Division of Pediatric Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center, MLC 2010, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.

Email: phillip.minar@cchmc.org

Search for more papers by this author

留言 (0)

沒有登入
gif